As the number of U.S covid cases continues to rise, an American pharmaceutical company applied for emergency authorization of the vaccine. The company, Pfizer along with BioNTech hope to produce upwards of 50 million doses of the vaccine in 2020 and 1.3 billion doses in 2021. The FDA will meet on Dec. 10 to decide whether or not to authorize the emergency release. If approved, the vaccine could be distributed as early as Dec. 11 or 12. If released, the vaccine will be distributed to states based on their population size, and it will then be up to the state to decide who gets it first. Likely, those at the highest risk of infection and workers on the front line will be given priority.
Julia Babinec
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment